EQX vs SOLS
Valuation
Profitability
Growth
Financial Health
Dividends
AI Verdict
Equinox Gold presents a stark contrast between valuation and fundamental health, highlighted by a weak Piotroski F-Score of 2/9. While the stock is attractively valued with a Forward P/E of 7.91 and a strong analyst target of $23.00, the deterministic health metrics indicate significant operational instability. Recent price performance has been exceptional over the last year, but a 0/100 technical trend and a massive -83.33% Q/Q revenue decline suggest a looming correction or operational pivot. The investment profile is currently speculative, relying on gold price tailwinds rather than internal financial strength.
SOLS exhibits a severe valuation disconnect, trading at $81.20 despite a Graham Number of $17.26 and an Intrinsic Value of $10.43. While the Piotroski F-Score of 5/9 indicates stable financial health, this is overshadowed by a catastrophic -69.3% collapse in earnings growth and a bearish technical trend (10/100). The company's high Debt/Equity ratio (1.84) and weak Quick Ratio (0.69) suggest liquidity risks that are not reflected in the current analyst 'Buy' consensus. Overall, the stock appears significantly overvalued relative to its fundamental performance and growth trajectory.
Compare Another Pair
Related Comparisons
EQX vs SOLS: Head-to-Head Comparison
This page compares Equinox Gold Corp. (EQX) and Solstice Advanced Materials, Inc. (SOLS) across key fundamental metrics including valuation ratios, profitability margins, growth rates, financial health indicators, and dividend metrics. Each metric highlights the better-performing stock so you can quickly identify relative strengths and weaknesses.
Our AI engine independently analyzes each company's financials, competitive position, and market conditions to produce a verdict (Bullish, Neutral, or Bearish) along with key strengths and risks. Use this comparison alongside your own research to make informed investment decisions.